Pfizer Inc. buy gerihouse
Start price
29.05.13
/
50%
€21.43
Target price
14.11.13
€23.72
Performance (%)
6.46%
End price
14.11.13
€22.47
Summary
This prediction ended on 14.11.13 with a price of €22.47. The BUY prediction by gerihouse finished with a performance of 6.46%. gerihouse has a follow-up prediction for Pfizer Inc. where he still thinks Pfizer Inc. is a Buy. gerihouse has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| Pfizer Inc. | -2.727% | -2.727% | -32.311% | -25.859% |
| iShares Core DAX® | 2.594% | -1.158% | 14.782% | 16.813% |
| iShares Nasdaq 100 | 3.553% | -1.727% | 43.265% | 44.227% |
| iShares Nikkei 225® | 0.687% | -8.354% | 18.454% | 1.361% |
| iShares S&P 500 | 2.209% | -0.942% | 31.361% | 42.812% |
According to gerihouse what are the pros and cons of Pfizer Inc. for the foreseeable future?
Pros
Could be worthwhile Investment >10% per year
Top 10 in its market
Known brand
Small cyclical dependencies
Future proof or reliable business model
Innovative
High dividend yield expected
Good rating
Cons
Comments by gerihouse for this prediction
In the thread Pfizer Inc. diskutieren
Weiterhin günstig
Update 25.10.:
Der weltweit größte Pharmakonzern Pfizer wird für das vierte Quartal 2013 unverändert eine Dividende von 24 US-Cents ausbezahlen. Auf das Jahr gerechnet werden somit weiterhin 0,96 US-Dollar ausgeschüttet. Beim derzeitigen Börsenkurs von 30,61 US-Dollar (Stand: 24. Oktober 2013) entspricht das einer aktuellen Dividendenrendite von 3,14 Prozent.
==============================================================
Obwohl der Patentschutz für Viagra ausläuft, weiterhin sehr günstig: KGV 13, Dividendenrendite 3,3%, KBV 2,48, EBIT Marge 31%
(Vom Mitglied beendet)
Current prediction by gerihouse for Pfizer Inc.
Pfizer Inc.
Start price
Target price
Perf. (%)
€33.25
27.07.23
27.07.23
€40.00
27.07.24
27.07.24
-24.06%
26.04.24
26.04.24
Could be worthwhile Investment >10% per year
Top 10 in its market
Known brand
Small cyclical dependencies
Stopped prediction by gerihouse for Pfizer Inc.
Pfizer Inc.
Start price
Target price
Perf. (%)
€46.84
04.04.22
04.04.22
€55.00
04.04.23
04.04.23
2.48%
16.04.22
16.04.22
Could be worthwhile Investment >10% per year
Top 10 in its market
Known brand
Small cyclical dependencies
Pfizer Inc.
Start price
Target price
Perf. (%)
€48.26
23.03.22
23.03.22
€55.00
23.03.23
23.03.23
-3.61%
02.04.22
02.04.22
Could be worthwhile Investment >10% per year
Top 10 in its market
Known brand
Small cyclical dependencies
Pfizer Inc.
Start price
Target price
Perf. (%)
€33.21
08.07.21
08.07.21
€55.00
08.07.22
08.07.22
29.12%
18.02.22
18.02.22
Could be worthwhile Investment >10% per year
Top 10 in its market
Known brand
Small cyclical dependencies
Pfizer Inc.
Start price
Target price
Perf. (%)
€30.93
04.08.20
04.08.20
€38.00
04.11.21
04.11.21
0.31%
13.04.21
13.04.21
Could be worthwhile Investment >10% per year
Top 10 in its market
Known brand
Small cyclical dependencies
Pfizer Inc.
Start price
Target price
Perf. (%)
€27.80
18.03.20
18.03.20
€37.95
07.05.20
07.05.20
23.39%
07.05.20
07.05.20
Could be worthwhile Investment >10% per year
Top 10 in its market
Known brand
Small cyclical dependencies
Pfizer Inc.
Start price
Target price
Perf. (%)
€36.41
20.02.19
20.02.19
€42.79
24.05.19
24.05.19
-0.28%
24.05.19
24.05.19
Could be worthwhile Investment >10% per year
Top 10 in its market
Known brand
Small cyclical dependencies
Pfizer Inc.
Start price
Target price
Perf. (%)
€30.10
28.10.15
28.10.15
€33.21
03.06.16
03.06.16
1.22%
03.06.16
03.06.16
Could be worthwhile Investment >10% per year
Top 10 in its market
Known brand
Small cyclical dependencies
Pfizer Inc.
Start price
Target price
Perf. (%)
€21.90
27.10.14
27.10.14
€25.62
12.12.14
12.12.14
11.39%
12.12.14
12.12.14
Could be worthwhile Investment >10% per year
Top 10 in its market
Known brand
Small cyclical dependencies
Pfizer Inc.
Start price
Target price
Perf. (%)
€21.31
22.04.14
22.04.14
€28.46
22.09.14
22.09.14
6.63%
22.09.14
22.09.14
Could be worthwhile Investment >10% per year
Top 10 in its market
Known brand
Small cyclical dependencies